Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 1 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
OCE PHARMA from Kapellen, company number BE0454218930, closed financial year 2025 with a result of € -343 after tax. For that financial year OCE PHARMA recorded a gross margin of € -178 and equity of € -46,568. Compared with financial year 2024, the result moved from € 134 to € -343. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ -46,568
▼ € 343 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -343
▼ still € 134 profit in 2024
Profit after tax over the fiscal year.
€ 537
▼ 39% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -65,160.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -553 | € -1,975 | € 68 | € -178 | ▼ € 246 |
| Profit after taxes | € -1,162 | € -2,225 | € 134 | € -343 | ▼ € 478 |
| Equity | € -44,134 | € -46,359 | € -46,225 | € -46,568 | ▼ € 343 |
| Total debts | € 46,765 | € 46,964 | € 47,105 | € 47,105 | |
| Cash | € 2,631 | € 605 | € 880 | € 537 | ▼ 39% |
| Retained profit | € -62,726 | € -64,951 | € -64,817 | € -65,160 | ▼ € 343 |
| Balance sheet total | € 2,631 | € 605 | € 880 | € 537 | ▼ 39% |
Key figures of OCE PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to OCE PHARMA?
What happened at OCE PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 343 (▼ € 478 vs 2024). Source: NBB ↗
- JP Enterprises BV became a director. NBB
- New establishment in Kapellen. KBO
- Start of the company according to the CBE. KBO
In short
From € 1,162 loss in 2022 to € 343 loss in 2025.
Best year ever: 2024, with € 134 profit.
Management
Behind OCE PHARMA is JP Enterprises BV. JP Enterprises BV is also behind NUTRIFARMA, Quality Gourmet Concepts and Bobiotics.
Directors
According to the 2025 annual accounts
Director · represented by Johan Picard
Also active at: NUTRIFARMA, Quality Gourmet Concepts, Bobiotics
since 2023
Establishments
Establishment units
Physical locations of this company
Heidestraat-Noord 4
2950 Kapellen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0454.218.930
- VAT number
- BE 0454.218.930
- Registered office
- Heidestraat-Noord 4, 2950 Kapellen
- Names & denominations
- OCE PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 January 1995
- Peppol
- Active · Active since 9 Dec 2025
- Activities · NACE
Groothandel in andere voedingsmiddelen, neg
Handelsbemiddeling in de groothandel in voedings- en genotmiddelen